Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Sales/Fixed Asset

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
   Sales/Fixed Asset(x) 1.612.512.491.95

What is the latest Sales/Fixed Asset ratio of GLAND PHARMA ?

The latest Sales/Fixed Asset ratio of GLAND PHARMA is 1.61 based on Mar2023 Consolidated results.
Year Sales/Fixed Asset
Mar20231.61
Mar20222.51
Mar20212.49
Mar20201.95

How is Sales/Fixed Asset of GLAND PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2023 1.61
-35.86
Mar2022 2.51
0.80
Mar2021 2.49
27.69
Mar2020 1.95 -

Other Financial Ratios of GLAND PHARMA


Compare Sales/Fixed Asset ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,732.2 Cr -2.6% -7.3% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.6%

-7.3%

26.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses